Early NRN Project leads to AIM listing
One of our initial projects with Profs Clarkson and Brancale in Cardiff, looking at new inhibitors of bcl3 to stop breast cancer metastasis has lead to a new spinout and listing on the london AIM market: Tiziana Life Sciences. The ticker symbol at AIM is TILS.